packageRociletinib

rociletinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rociletinib is an investigational EGFR tyrosine kinase inhibitor studied as a cancer treatment. It has not been approved; it remains an investigational drug and is not in general clinical use.

Summary written by glm-5.3-flash from Wikidata Q28208946 and the WHO ATC classification; not checked by a person.

name:rociletinib
ATC codes:L01EB05
DrugBank:DB11907
PubChem CID:57335384
Wikidata:Q28208946
formula:C27H28F3N7O3
molar mass:555.561 g/mol (PubChem CID 57335384)
logP:4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown